Cargando…
Developments in the management of autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent life- threatening, hereditary disease. ADPKD is more common than sickle cell anemia, cystic fibrosis, muscular dystrophy, hemophilia, Down’s syndrome, and Huntington’s disease combined. ADPKD is a multisystemic disorder charac...
Autores principales: | Masoumi, Amirali, Reed-Gitomer, Berenice, Kelleher, Catherine, Bekheirnia, Mir Reza, Schrier, Robert W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504069/ https://www.ncbi.nlm.nih.gov/pubmed/18728845 |
Ejemplares similares
-
Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease
por: Baliga, Madhurima M., et al.
Publicado: (2021) -
Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
por: Nowak, Kristen L., et al.
Publicado: (2018) -
A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Perrone, Ronald D., et al.
Publicado: (2017) -
CD8(+) T cells modulate autosomal dominant polycystic kidney disease progression
por: Kleczko, Emily K., et al.
Publicado: (2018) -
Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)